Proteases at the endometrial-trophoblast interface: Their role in implantation

Reviews in Endocrine and Metabolic Disorders

Volumn 3, Issue 2, 2002, Pages 133-143

  Salamonsen, Lois A ^a   Nie, Guiying ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Cysteine protease; Embryo maternal; Implantation; Matrix metalloproteinase; Serine protease

Indexed keywords

CYSTEINE PROTEINASE; MATRIX METALLOPROTEINASE; PROTEINASE; SERINE PROTEINASE;

CELL INTERACTION; ENDOMETRIUM; ENZYME ACTIVITY; ENZYME DEGRADATION; HUMAN; MUTATION; NIDATION; NONHUMAN; PROTEIN EXPRESSION; REVIEW; TROPHOBLAST; ANIMAL; CELL COMMUNICATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; PREGNANCY;

ANIMAL; CELL COMMUNICATION; EMBRYO IMPLANTATION; ENDOMETRIUM; ENDOPEPTIDASES; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMAN; PREGNANCY; SUPPORT, NON-U.S. GOV'T; TROPHOBLASTS; ANIMALS; HUMANS;

EID: 0035985015     PISSN: 13899155     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015407012559     Document Type: Review

References (96)

1. Endometrial leukocytes and menstruation
2. Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases
3. Structure and function of interleukin-1 beta converting enzyme
4. Physiological mechanisms for metalloproteinase activation
5. Effective activation of the proenzyme form of the urokinase-type plasminogen activator (pro-uPA) by the cysteine protease cathepsin L
6. "In vitro" study of basement membrane degradation by the cysteine proteinases, cathepsins B, B-like and L. Digestion of collagen IV, laminin, fibronectin, and release of gelatinase activities from basement membrane fibronectin
7. Cathepsins D and B in breast cancer
8. The plasminogen activator/plasmin system
9. Roles of the insulinlike growth factor family in nonpregnant human endometrium and at the decidual: Trophoblast interface
10. Regulation of IGF bioavailability in pregnancy
11. Novel aspects of the insulin-like growth factor binding proteins
12. 7S nerve growth factor is an insulin-like growth factor-binding protein protease
13. Recombinant human insulin-like growth factor (IGF) binding protein-3 stimulates prostate carcinoma cell proliferation via an IGF-dependent mechanism. Role of serine proteases
14. Murine subtilisin-like proteinase SPC6 is expressed during embryonic implantation, somitogenesis, and skeletal formation
15. Cellular biochemistry of the endometrium
16. Deposition of hyaluronan in human endometrium across the menstrual cycle: Implications for implantation and menstruation
17. The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases
18. Degradation of decorin by matrix metalloproteinases: Identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release
19. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis
20. Insulin-like growth factor II signaling in neoplastic proliferation is blocked by transgenic expression of the metalloproteinase inhibitor TIMP-1
21. Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor
22. Generation of biologically active IL-1 beta by matrix metalloproteinases: A novel caspase-1-independent pathway of IL-1 beta processing
23. Degradation of interleukin 1beta by matrix metalloproteinases
24. Matrix metalloproteinases generate angiostatin: Effects on neovascularization
25. Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9)
26. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
27. Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules
28. TIMP-2 is required for efficient activation of proMMP-2 in vivo
29. Growth promoting activity of tissue inhibitor of metalloproteinases (TIMP-1) for a wide range of cells
30. Cell growth promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2)
31. Identification of a stimulator of steroid hormone synthesis isolated from testis
32. Tissue inhibitor of metalloproteinases (TIMP-1) produced by granulosa and oviduct cells enhances in vitro development of bovine embryos
33. Divergent effects of tissue inhibitor of metalloproteinase-1, -2 or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation and death in vitro
34. The expression and function of cystatin C and cathepsin B and cathepsin L during mouse embryo implantation and placentation
35. Expression of cathepsin proteinases by mouse trophoblast in vivo and in vitro
36. 92-kDa type IV collagenase and TIMP-3, but not 72-kDa type IV collagenase or TIMP-1 or TIMP-2, are highly expressed during mouse embryo implantation
37. Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation
38. Tissue inhibitor of metalloproteinases-3 is the major metalloproteinase inhibitor in the decidualizing murine uterus
39. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the mouse uterus during the peri-implantation period
40. Expression of matrix metalloproteinases 2 and 9 in the mouse uterus during implantation and oil-induced decidualization
41. Proteinase expression in early mouse embyros is regulated by leukaemia inhibitory factor and epidermal growth factor
42. Matrix metalloproteinase-9 and tissue inhibitor of metallo-proteinase-3 are key regulators of extracellular matrix degradation by mouse embryos
43. Matrix metalloproteinases and their endogenous inhibitors during the implantation period in the rat uterus
44. Effect of inhibition of matrix metalloproteinases on endometrial decidualization and implantation in mated rats
45. Identification and enzymatic characterization of two diverging murine counterparts of human interstitial collagenase (MMP-1) expressed at sites of embryo implantation
46. Matrilysin activity in the rat uterus during the oestrous cycle and implantation
47. Embryo implantation in mouse: Fetomaternal coordination in the pattern of expression of uPA, uPAR, PAI-1 and alpha 2MR/LRP genes
48. Increased expression and localization of a serine protease inhibitor, protease nexin-1 (pn-1), in the ovary and uterus during implantation in rat
49. Regulation of the strypsin-related proteinase ISP2 by progesterone in endometrial gland epithelium during implantation in mice
50. Plasminogen activators and inhibitors are transcribed during early macaque implantation
51. Expression of urokinase, plasminogen activator inhibitors and urokinase receptor in pregnant rhesus monkey uterus during early placentation
52. Does plasminogen activator inhibitor-1 (PAI-1) control trophoblast invasion A study of fetal and maternal tissue in intrauterine, tubal and molar pregnancies
53. Interleukin-1 beta regulates urokinase plasminogen activator (u-PA), u-PA receptor, soluble u-PA receptor, and plasminogen activator inhibitor-1 messenger ribonucleic acid expression in cultured human endometrial stromal cells
54. Immunohistochemical profile of basement membrane proteins and 72 kilodalton type IV collagenase in the implantation placental site
55. Expression of matrix metalloproteinase-2, -9, -14, and tissue inhibitors of metalloproteinase-1, -2, -3 in the endometrium and placenta of rhesus monkey (Macaca mulatta) during early pregnancy
56. Immunolocalization of the matrix metalloproteinases, gelatinase B and stromelysin-1 in human endometrium throughout the menstrual cycle
57. Progesterone inhibits activation of latent matrix metalloproteinase (MMP)-2 by membrane-type 1 MMP: Enzymes coordinately expressed in human endometrium
58. Tissue inhibitor of metalloproteinases (TIMP)-1, -2 and -3 in human endometrium during the menstrual cycle
59. Matrix metalloproteinases in normal menstruation
60. Endometrial leukocytes are altered numerically and functionally in women with implantation defects
61. Coordinate expression of matrix metalloproteinase family members in the uterus of normal, matrilysin-deficient, and stromelysin-1-deficient mice
62. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes
63. Experimental metastasis is suppressed in MMP-9-deficient mice
64. Molecular genetics of implantation in the mouse
65. Disruption of the tissue inhibitor of metalloproteinase-1 gene results in altered reproductive cyclicity and uterine morphology in reproductive-age female mice
66. Basigin (murine EMMPRIN) stimulates matrix metalloproteinase production by fibroblasts
67. A null mutation in basigin, an immunoglobulin superfamily member, indicates its important roles in peri-implantation development and spermatogenesis
68. Female sterility in mice lacking the basigin gene, which encodes a transmembrane glycoprotein belonging to the immunoglobulin superfamily
69. The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily
70. Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts
71. EMMPRIN (CD147), an inducer of matrix metalloproteinase synthesis, also binds interstitial collagenase to the tumor cell surface
72. Transcription factors Ets1, Ets2 and Elf1 exhibit differential localization in human endometrium across the menstrual cycle and alternate isoforms in cultured endometrial cells
73. Defective trophoblast function in mice with a targeted mutation of Ets2
74. JunB is essential for mammalian placentation
75. A targeted mutation at the known collagenase cleavage site in mouse type I collagen impairs tissue remodeling
76. Matrix metalloproteinases as insulin-like growth factor binding protein degrading proteinases
77. Characterization of insulin-like growth factor-binding protein 5-degrading proteases produced throughout murine osteoblast differentiation
78. Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site
79. Cleavage of beta 4 integrin by matrilysin
80. Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1
81. Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9
82. Modulation of the biological functions of galectin-3 by matrix metalloproteinases
83. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system
84. The cleavage of pro-urokinase type plasminogen activator by stromelysin-1
85. Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3)
86. Kinetics and physiologic relevance of the inactivation of alpha 1-proteinase inhibitor, alpha 1-antichymotrypsin, and antithrombin III by matrix metalloproteinases-1 (tissue collagenase), -2 (72-kDa gelatinase/type IV collagenase), and -3 (stromelysin)
87. Physiological consequences of loss of plasminogen activator gene function in mice
88. The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility
89. Biological effects of disruption of the tissue-type plasminogen activator, urokinase-type plasminogen activator and plasminogen activator inhibitor-1 genes in mice
90. Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice
91. Unaltered secretion of beta-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice
92. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover
93. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase 1
94. Targeted inactivation of the mouse alpha 2-macroglobulin gene